LMNB1 and lung carcinoma: Since our findings revealed decreased expression of lamin B1 in the majority of lung carcinoma patients, targeting of RET, or p38 signaling, might be a valuable therapeutic strategy for a significant fraction of human lung tumors caused by perturbation of the lamin B1–EZH2 axis.